Annual report pursuant to Section 13 and 15(d)

Equity - Schedule of Proceeds From Initial Public Offering (Details)

v3.3.1.900
Equity - Schedule of Proceeds From Initial Public Offering (Details) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Gross Proceeds: $ 14,998,500  
Payments of Stock Issuance Costs $ 13,101,336 $ 1,897,164
Net Proceeds: $ 13,101,336
Underwriter And Aegis Expenses [Member]    
Payments of Stock Issuance Costs $ 1,344,055  
Underwriter And Aegis Expenses [Member] | Underwriter Commission [Member]    
Payments of Stock Issuance Costs 1,049,895  
Underwriter And Aegis Expenses [Member] | Underwriter Expenses [Member]    
Payments of Stock Issuance Costs 149,985  
Underwriter And Aegis Expenses [Member] | Aegis Legal Fees [Member]    
Payments of Stock Issuance Costs 80,000  
Underwriter And Aegis Expenses [Member] | Aegis Registration Expenses [Member]    
Payments of Stock Issuance Costs 7,500  
Underwriter And Aegis Expenses [Member] | Aegis Miscellaneous Expenses [Member]    
Payments of Stock Issuance Costs 36,675  
Underwriter And Aegis Expenses [Member] | Aegis Road Show Expenses [Member]    
Payments of Stock Issuance Costs 20,000  
Akers Biosciences Expenses [Member]    
Payments of Stock Issuance Costs 553,109  
Akers Biosciences Expenses [Member] | Legal Accounting Expenses [Member]    
Payments of Stock Issuance Costs 393,298  
Akers Biosciences Expenses [Member] | Printing Document Prep [Member]    
Payments of Stock Issuance Costs 62,101  
Akers Biosciences Expenses [Member] | Registration Expenses [Member]    
Payments of Stock Issuance Costs 55,946  
Akers Biosciences Expenses [Member] | Road Show Expenses [Member]    
Payments of Stock Issuance Costs $ 41,764